Overview
Compile real-world outcomes of commercially approved Intraceptâ„¢ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
Description
The objective of this study is to compile real-world outcomes of commercially approved Intraceptâ„¢ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.
Eligibility
Inclusion Criteria:
- Study candidate is scheduled to be treated with a commercially approved Intraceptâ„¢ Intraosseous Nerve Ablation System per local Instructions for Use (IFU).
- Signed a valid, IRB/EC-approved informed consent form.
Exclusion Criteria:
- Meets any contraindications per locally applicable Instructions for Use (IFU).